Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 231

1.

Approche diagnostique et thérapeutique de la vasculopathie polypoïdale choroïdienne. Recommandations de la Fédération France Macula.

Srour M, Sayag D, Nghiem-Buffet S, Arndt C, Creuzot-Garcher C, Souied E, Mauget-Faÿsse M.

J Fr Ophtalmol. 2019 Jun 4. pii: S0181-5512(19)30268-2. doi: 10.1016/j.jfo.2019.05.002. [Epub ahead of print] French.

PMID:
31174880
2.

Subfoveal Choroidal Thickness, Cardiovascular History, and Risk Factors in the Elderly: The Montrachet Study.

Arnould L, Seydou A, Gabrielle PH, Guenancia C, Tzourio C, Bourredjem A, El Alami Y, Daien V, Binquet C, Bron AM, Creuzot-Garcher C.

Invest Ophthalmol Vis Sci. 2019 Jun 3;60(7):2431-2437. doi: 10.1167/iovs.18-26488.

PMID:
31158275
3.

Retinal Vascular Density as A Novel Biomarker of Acute Renal Injury after Acute Coronary Syndrome.

Alan G, Guenancia C, Arnould L, Azemar A, Pitois S, Maza M, Bichat F, Zeller M, Gabrielle PH, Bron AM, Creuzot-Garcher C, Cottin Y.

Sci Rep. 2019 May 30;9(1):8060. doi: 10.1038/s41598-019-44647-9.

4.

Alteration of erythrocyte membrane polyunsaturated fatty acids in preterm newborns with retinopathy of prematurity.

Pallot C, Mazzocco J, Meillon C, Semama DS, Chantegret C, Ternoy N, Martin D, Donier A, Gregoire S, Creuzot-Garcher CP, Bron AM, Bretillon L, Acar N.

Sci Rep. 2019 May 28;9(1):7930. doi: 10.1038/s41598-019-44476-w.

5.

Vitreomacular Interface Abnormalities and Glaucoma in an Elderly Population (The MONTRACHET Study).

Blanc J, Seydou A, Ben Ghezala I, Deschasse C, Meillon C, Bron AM, Binquet C, Creuzot-Garcher C.

Invest Ophthalmol Vis Sci. 2019 May 1;60(6):1996-2002. doi: 10.1167/iovs.18-26510.

PMID:
31067319
6.

Real-World Outcomes with Ranibizumab 0.5 mg in Patients with Visual Impairment due to Diabetic Macular Edema: 12-Month Results from the 36-Month BOREAL-DME Study.

Massin P, Creuzot-Garcher C, Kodjikian L, Girmens JF, Delcourt C, Fajnkuchen F, Glacet-Bernard A, Guillausseau PJ, Ponthieux A, Blin P, Grelaud A.

Ophthalmic Res. 2019;62(2):101-110. doi: 10.1159/000497406. Epub 2019 Mar 29.

PMID:
30928985
7.

Visual outcomes and complications of congenital cataract surgery.

Louison S, Blanc J, Pallot C, Alassane S, Praudel A, Bron AM, Creuzot-Garcher C.

J Fr Ophtalmol. 2019 Apr;42(4):368-374. doi: 10.1016/j.jfo.2018.10.007. Epub 2019 Mar 18.

PMID:
30898370
8.

Oestrus ovis external ophtalmomyiasis: a case report in Burgundy France.

Basmaciyan L, Gabrielle PH, Valot S, Sautour M, Buisson JC, Creuzot-Garcher C, Dalle F.

BMC Ophthalmol. 2018 Dec 22;18(1):335. doi: 10.1186/s12886-018-1003-z.

9.

Central retinal thickness following panretinal photocoagulation using a multispot semi-automated pattern-scanning laser to treat ischaemic diabetic retinopathy: Treatment in one session compared with four monthly sessions.

Gabrielle PH, Massin P, Kodjikian L, Erginay A, Pallot C, Jonval L, Soudry A, Couturier A, Vardanian-Vartin C, Bron AM, Creuzot-Garcher C.

Acta Ophthalmol. 2019 Aug;97(5):e680-e687. doi: 10.1111/aos.14002. Epub 2018 Dec 18.

PMID:
30561087
10.

The EYE-MI Pilot Study: A Prospective Acute Coronary Syndrome Cohort Evaluated With Retinal Optical Coherence Tomography Angiography.

Arnould L, Guenancia C, Azemar A, Alan G, Pitois S, Bichat F, Zeller M, Gabrielle PH, Bron AM, Creuzot-Garcher C, Cottin Y.

Invest Ophthalmol Vis Sci. 2018 Aug 1;59(10):4299-4306. doi: 10.1167/iovs.18-24090.

PMID:
30372758
11.

Increased High-Density Lipoprotein Levels Associated with Age-Related Macular Degeneration: Evidence from the EYE-RISK and European Eye Epidemiology Consortia.

Colijn JM, den Hollander AI, Demirkan A, Cougnard-Grégoire A, Verzijden T, Kersten E, Meester-Smoor MA, Merle BMJ, Papageorgiou G, Ahmad S, Mulder MT, Costa MA, Benlian P, Bertelsen G, Bron AM, Claes B, Creuzot-Garcher C, Erke MG, Fauser S, Foster PJ, Hammond CJ, Hense HW, Hoyng CB, Khawaja AP, Korobelnik JF, Piermarocchi S, Segato T, Silva R, Souied EH, Williams KM, van Duijn CM, Delcourt C, Klaver CCW; European Eye Epidemiology Consortium; EYE-RISK Consortium.

Ophthalmology. 2019 Mar;126(3):393-406. doi: 10.1016/j.ophtha.2018.09.045. Epub 2018 Oct 10.

PMID:
30315903
12.

Antiplatelet and anticoagulant agents in vitreoretinal surgery: a prospective multicenter study involving 804 patients.

Meillon C, Gabrielle PH, Bron AM, Creuzot-Garcher C.

Graefes Arch Clin Exp Ophthalmol. 2019 Feb;257(2):427. doi: 10.1007/s00417-018-4152-0. Epub 2018 Sep 24. No abstract available.

PMID:
30251200
13.

Association of Acute Endophthalmitis With Intravitreal Injections of Corticosteroids or Anti-Vascular Growth Factor Agents in a Nationwide Study in France.

Baudin F, Benzenine E, Mariet AS, Bron AM, Daien V, Korobelnik JF, Quantin C, Creuzot-Garcher C.

JAMA Ophthalmol. 2018 Dec 1;136(12):1352-1358. doi: 10.1001/jamaophthalmol.2018.3939.

PMID:
30242325
14.

Response to safety and long-term efficacy of repeated dexamethasone intravitreal implant for the treatment of cystoid macular edema secondary to retinal vein occlusion with and without a switch to anti-VEGF agents: a 3-year experience.

Blanc J, Kodjikian L, Bron A, Creuzot-Garcher C.

Graefes Arch Clin Exp Ophthalmol. 2018 Nov;256(11):2271. doi: 10.1007/s00417-018-4095-5. No abstract available.

PMID:
30084068
15.

Is combined cataract surgery associated with acute postoperative endophthalmitis? A nationwide study from 2005 to 2014.

Creuzot-Garcher CP, Mariet AS, Benzenine E, Daien V, Korobelnik JF, Bron AM, Quantin C.

Br J Ophthalmol. 2019 Apr;103(4):534-538. doi: 10.1136/bjophthalmol-2018-312171. Epub 2018 Jun 20.

PMID:
29925513
16.

Safety and long-term efficacy of repeated dexamethasone intravitreal implants for the treatment of cystoid macular edema secondary to retinal vein occlusion with or without a switch to anti-VEGF agents: a 3-year experience.

Blanc J, Deschasse C, Kodjikian L, Dot C, Bron AM, Creuzot-Garcher C.

Graefes Arch Clin Exp Ophthalmol. 2018 Aug;256(8):1441-1448. doi: 10.1007/s00417-018-4016-7. Epub 2018 May 31.

PMID:
29855706
17.

Association of Anticholinergic Drug Use With Risk for Late Age-Related Macular Degeneration.

Aldebert G, Faillie JL, Hillaire-Buys D, Mura T, Carrière I, Delcourt C, Creuzot-Garcher C, Villain M, Daien V.

JAMA Ophthalmol. 2018 Jul 1;136(7):770-778. doi: 10.1001/jamaophthalmol.2018.1719.

18.

Dietary, environmental, and genetic risk factors of Extensive Macular Atrophy with Pseudodrusen, a severe bilateral macular atrophy of middle-aged patients.

Douillard A, Picot MC, Delcourt C, Defoort-Dhellemmes S, Marzouka NA, Lacroux A, Zanlonghi X, Drumare I, Jozefowicz E, Bocquet B, Baudoin C, Perez-Roustit S, Arsène S, Gissot V, Devin F, Arndt C, Wolff B, Mauget-Faÿsse M, Quaranta M, Mura T, Deplanque D, Oubraham H, Cohen SY, Gastaud P, Zambrowski O, Creuzot-Garcher C, Saïd SM, Sahel JA, Souied E, Milazzo S, Garavito RB, Kalatzis V, Puech B, Hamel C, Audo I, Meunier I.

Sci Rep. 2018 May 1;8(1):6840. doi: 10.1038/s41598-018-25003-9.

19.

Systemic and Ocular Determinants of Peripapillary Retinal Nerve Fiber Layer Thickness Measurements in the European Eye Epidemiology (E3) Population.

Mauschitz MM, Bonnemaijer PWM, Diers K, Rauscher FG, Elze T, Engel C, Loeffler M, Colijn JM, Ikram MA, Vingerling JR, Williams KM, Hammond CJ, Creuzot-Garcher C, Bron AM, Silva R, Nunes S, Delcourt C, Cougnard-Grégoire A, Holz FG, Klaver CCW, Breteler MMB, Finger RP; European Eye Epidemiology (E3) Consortium.

Ophthalmology. 2018 Oct;125(10):1526-1536. doi: 10.1016/j.ophtha.2018.03.026. Epub 2018 Apr 30.

PMID:
29716786
20.

Association between the retinal vascular network with Singapore "I" Vessel Assessment (SIVA) software, cardiovascular history and risk factors in the elderly: The Montrachet study, population-based study.

Arnould L, Binquet C, Guenancia C, Alassane S, Kawasaki R, Daien V, Tzourio C, Kawasaki Y, Bourredjem A, Bron A, Creuzot-Garcher C.

PLoS One. 2018 Apr 3;13(4):e0194694. doi: 10.1371/journal.pone.0194694. eCollection 2018.

21.

Antiplatelet and anticoagulant agents in vitreoretinal surgery: a prospective multicenter study involving 804 patients.

Meillon C, Gabrielle PH, Bron A, Creuzot-Garcher C.

Graefes Arch Clin Exp Ophthalmol. 2018 Jul;256(7):1359. doi: 10.1007/s00417-018-3969-x. Epub 2018 Mar 30. No abstract available.

PMID:
29602959
22.

The Decreasing Prevalence of Nonrefractive Visual Impairment in Older Europeans: A Meta-analysis of Published and Unpublished Data.

Delcourt C, Le Goff M, von Hanno T, Mirshahi A, Khawaja AP, Verhoeven VJM, Hogg RE, Anastosopoulos E, Cachulo ML, Höhn R, Wolfram C, Bron A, Miotto S, Carrière I, Colijn JM, Buitendijk GHS, Evans J, Nitsch D, Founti P, Yip JLY, Pfeiffer N, Creuzot-Garcher C, Silva R, Piermarocchi S, Topouzis F, Bertelsen G, Foster PJ, Fletcher A, Klaver CCW, Korobelnik JF; European Eye Epidemiology Consortium.

Ophthalmology. 2018 Aug;125(8):1149-1159. doi: 10.1016/j.ophtha.2018.02.005. Epub 2018 Mar 13.

23.

Topical ocular 0.1% cyclosporine A cationic emulsion in dry eye disease patients with severe keratitis: experience through the French early-access program.

Pisella PJ, Labetoulle M, Doan S, Cochener-Lamard B, Amrane M, Ismail D, Creuzot-Garcher C, Baudouin C.

Clin Ophthalmol. 2018 Feb 5;12:289-299. doi: 10.2147/OPTH.S150957. eCollection 2018.

24.

Ranibizumab Plus Panretinal Photocoagulation versus Panretinal Photocoagulation Alone for High-Risk Proliferative Diabetic Retinopathy (PROTEUS Study).

Figueira J, Fletcher E, Massin P, Silva R, Bandello F, Midena E, Varano M, Sivaprasad S, Eleftheriadis H, Menon G, Amaro M, Ayello Scheer S, Creuzot-Garcher C, Nascimento J, Alves D, Nunes S, Lobo C, Cunha-Vaz J; EVICR.net Study Group.

Ophthalmology. 2018 May;125(5):691-700. doi: 10.1016/j.ophtha.2017.12.008. Epub 2018 Feb 1.

PMID:
29395119
25.

Did case-based payment influence surgical readmission rates in France? A retrospective study.

Vuagnat A, Yilmaz E, Roussot A, Rodwin V, Gadreau M, Bernard A, Creuzot-Garcher C, Quantin C.

BMJ Open. 2018 Feb 1;8(2):e018164. doi: 10.1136/bmjopen-2017-018164.

26.

Antiplatelet and anticoagulant agents in vitreoretinal surgery: a prospective multicenter study involving 804 patients.

Meillon C, Gabrielle PH, Luu M, Aho-Glele LS, Bron AM, Creuzot-Garcher C; CFSR research net.

Graefes Arch Clin Exp Ophthalmol. 2018 Mar;256(3):461-467. doi: 10.1007/s00417-017-3897-1. Epub 2018 Jan 23.

PMID:
29362869
27.

[Retinal phacomas in tuberous sclerosis in a 18-year old patient].

Barrenechea E, Deschasse C, Baudin F, Bron AM, Creuzot Garcher C.

J Fr Ophtalmol. 2017 Dec;40(10):898-900. doi: 10.1016/j.jfo.2017.03.023. Epub 2017 Nov 14. French. No abstract available.

28.

Effect of Dietary Supplementation With Lutein, Zeaxanthin, and ω-3 on Macular Pigment: A Randomized Clinical Trial.

Korobelnik JF, Rougier MB, Delyfer MN, Bron A, Merle BMJ, Savel H, Chêne G, Delcourt C, Creuzot-Garcher C.

JAMA Ophthalmol. 2017 Nov 1;135(11):1259-1266. doi: 10.1001/jamaophthalmol.2017.3398.

29.

Dry eye disease in the elderly in a French population-based study (the Montrachet study: Maculopathy, Optic Nerve, nuTRition, neurovAsCular and HEarT diseases): Prevalence and associated factors.

Ferrero A, Alassane S, Binquet C, Bretillon L, Acar N, Arnould L, Muselier-Mathieu A, Delcourt C, Bron AM, Creuzot-Garcher C.

Ocul Surf. 2018 Jan;16(1):112-119. doi: 10.1016/j.jtos.2017.09.008. Epub 2017 Sep 20.

PMID:
28939118
30.

Screening for Retinopathy of Prematurity: Insight into Optimizing Screening.

Pallot C, Soudry Faure A, Charvy C, Ternoy N, Langlet Muteau C, Acar N, Bron AM, Speeg Schatz C, Creuzot-Garcher C.

Ophthalmic Res. 2018;59(4):228-234. doi: 10.1159/000477622. Epub 2017 Jul 27.

PMID:
28746942
31.

Prevalence of Age-Related Macular Degeneration in Europe: The Past and the Future.

Colijn JM, Buitendijk GHS, Prokofyeva E, Alves D, Cachulo ML, Khawaja AP, Cougnard-Gregoire A, Merle BMJ, Korb C, Erke MG, Bron A, Anastasopoulos E, Meester-Smoor MA, Segato T, Piermarocchi S, de Jong PTVM, Vingerling JR, Topouzis F, Creuzot-Garcher C, Bertelsen G, Pfeiffer N, Fletcher AE, Foster PJ, Silva R, Korobelnik JF, Delcourt C, Klaver CCW; EYE-RISK consortium; European Eye Epidemiology (E3) consortium.

Ophthalmology. 2017 Dec;124(12):1753-1763. doi: 10.1016/j.ophtha.2017.05.035. Epub 2017 Jul 14.

32.

Cholesterol metabolism and glaucoma: Modulation of Muller cell membrane organization by 24S-hydroxycholesterol.

Gambert S, Gabrielle PH, Masson E, Leger-Charnay E, Ferrerro A, Vannier A, Gendrault C, Lachot M, Creuzot-Garcher C, Bron A, Gregoire S, Leclere L, Martine L, Lucchi G, Truntzer C, Pecqueur D, Bretillon L.

Chem Phys Lipids. 2017 Oct;207(Pt B):179-191. doi: 10.1016/j.chemphyslip.2017.05.007. Epub 2017 Jun 4.

PMID:
28576383
33.

[Spasm of iris dilator muscle or tadpole-shaped pupil].

Deschasse C, Baudin F, Gabrielle PH, Bron AM, Creuzot-Garcher C.

J Fr Ophtalmol. 2017 Jun;40(6):522-523. doi: 10.1016/j.jfo.2016.12.019. Epub 2017 May 29. French. No abstract available.

34.

Intraocular Cytokine Levels in Post-Cataract Endophthalmitis and their Association with Visual Outcome.

Sauer A, Candolfi E, Gaucher D, Creuzot-Garcher C, Bron A, Chiquet C, Berrod JP, Meyer N, Prevost G, Bourcier T.

Ocul Immunol Inflamm. 2018;26(6):964-970. doi: 10.1080/09273948.2017.1310253. Epub 2017 Apr 28.

PMID:
28453374
35.

French Medical-Administrative Database for Epidemiology and Safety in Ophthalmology (EPISAFE): The EPISAFE Collaboration Program in Cataract Surgery.

Daien V, Korobelnik JF, Delcourt C, Cougnard-Gregoire A, Delyfer MN, Bron AM, Carrière I, Villain M, Daures JP, Lacombe S, Mariet AS, Quantin C, Creuzot-Garcher C.

Ophthalmic Res. 2017;58(2):67-73. doi: 10.1159/000456721. Epub 2017 Apr 4. Review.

36.

Miscellaneous.

Creuzot-Garcher C.

Dev Ophthalmol. 2017;58:220-237. doi: 10.1159/000455283. Epub 2017 Mar 28. Review.

PMID:
28351050
37.

Trends in operating room-based glaucoma procedures in France from 2005 to 2014: a nationwide study.

Bron AM, Mariet AS, Benzenine E, Arnould L, Daien V, Korobelnik JF, Quantin C, Creuzot-Garcher C.

Br J Ophthalmol. 2017 Nov;101(11):1500-1504. doi: 10.1136/bjophthalmol-2016-309946. Epub 2017 Mar 14.

PMID:
28292777
38.

Plasma long-chain omega-3 polyunsaturated fatty acids and macular pigment in subjects with family history of age-related macular degeneration: the Limpia Study.

Merle BMJ, Buaud B, Korobelnik JF, Bron A, Delyfer MN, Rougier MB, Savel H, Vaysse C, Creuzot-Garcher C, Delcourt C.

Acta Ophthalmol. 2017 Dec;95(8):e763-e769. doi: 10.1111/aos.13408. Epub 2017 Mar 8.

39.

Longitudinal study of retinal status using optical coherence tomography after acute onset endophthalmitis following cataract surgery.

Zhou T, Aptel F, Bron AM, Cornut PL, Palombi K, Thuret G, Rouberol F, Creuzot-Garcher C, Chiquet C.

Br J Ophthalmol. 2017 Sep;101(9):1211-1216. doi: 10.1136/bjophthalmol-2016-309542. Epub 2017 Jan 24.

PMID:
28119290
40.

Comparison of Recent Studies of Postoperative Endophthalmitis From the Same National Database-Reply.

Daien V, Villain M, Creuzot-Garcher C.

JAMA Ophthalmol. 2017 Feb 1;135(2):174-175. doi: 10.1001/jamaophthalmol.2016.5107. No abstract available.

PMID:
28033434
41.

Ganglioside Profiling of the Human Retina: Comparison with Other Ocular Structures, Brain and Plasma Reveals Tissue Specificities.

Sibille E, Berdeaux O, Martine L, Bron AM, Creuzot-Garcher CP, He Z, Thuret G, Bretillon L, Masson EA.

PLoS One. 2016 Dec 20;11(12):e0168794. doi: 10.1371/journal.pone.0168794. eCollection 2016.

42.

Long-Term Anatomical and Functional Outcomes after Combined Cataract and Idiopathic Epiretinal Membrane Surgery.

Kauffmann Y, Ramel JC, Isaico R, De Lazzer A, Bron AM, Creuzot-Garcher C.

Ophthalmic Res. 2017;57(2):125-134. doi: 10.1159/000452837. Epub 2016 Dec 20.

PMID:
27992872
43.

Postoperative Ocular Inflammation: A Single Subconjunctival Injection of XG-102 Compared to Dexamethasone Drops in a Randomized Trial.

Chiquet C, Aptel F, Creuzot-Garcher C, Berrod JP, Kodjikian L, Massin P, Deloche C, Perino J, Kirwan BA, de Brouwer S, Combette JM, Behar-Cohen F.

Am J Ophthalmol. 2017 Feb;174:76-84. doi: 10.1016/j.ajo.2016.10.012. Epub 2016 Nov 1.

44.

Dominant variants in the splicing factor PUF60 cause a recognizable syndrome with intellectual disability, heart defects and short stature.

El Chehadeh S, Kerstjens-Frederikse WS, Thevenon J, Kuentz P, Bruel AL, Thauvin-Robinet C, Bensignor C, Dollfus H, Laugel V, Rivière JB, Duffourd Y, Bonnet C, Robert MP, Isaiko R, Straub M, Creuzot-Garcher C, Calvas P, Chassaing N, Loeys B, Reyniers E, Vandeweyer G, Kooy F, Hančárová M, Havlovicová M, Prchalová D, Sedláček Z, Gilissen C, Pfundt R, Wassink-Ruiter JS, Faivre L.

Eur J Hum Genet. 2016 Jan;25(1):43-51. doi: 10.1038/ejhg.2016.133. Epub 2016 Nov 2.

45.

Spatial Distribution of Macular Pigment in an Elderly French Population: The Montrachet Study.

Alassane S, Binquet C, Arnould L, Fleck O, Acar N, Delcourt C, Bretillon L, Bron AM, Creuzot-Garcher C.

Invest Ophthalmol Vis Sci. 2016 Aug 1;57(10):4469-4475. doi: 10.1167/iovs.16-19958.

PMID:
27750290
46.

Procedural aspects of the organization of the comprehensive European Board of Ophthalmology Diploma examination.

Mathysen DG, Ringens PJ, Midena E, Klett A, Sunaric-Mégevand G, Martinez-Costa R, Curtin D, Tassignon MJ, Aclimandos W, Creuzot-Garcher C, Grupcheva C.

J Educ Eval Health Prof. 2016 Jul 26;13:27. eCollection 2016. Review.

47.

Can 'Fellow of the European Board of Ophthalmology Subspecialty Diploma in Glaucoma,' a subspecialty examination on glaucoma induce the qualification standard of glaucoma clinical practice in Europe?

Sunaric-Mégevand G, Aclimandos W, Creuzot-Garcher C, Traverso CE, Tuulonen A, Hitchings R, Mathysen DG.

J Educ Eval Health Prof. 2016 Jul 28;13:28. eCollection 2016. No abstract available.

48.

Associations with intraocular pressure across Europe: The European Eye Epidemiology (E3) Consortium.

Khawaja AP, Springelkamp H, Creuzot-Garcher C, Delcourt C, Hofman A, Höhn R, Iglesias AI, Wolfs RC, Korobelnik JF, Silva R, Topouzis F, Williams KM, Bron AM, Buitendijk GH, Cachulo MD, Cougnard-Grégoire A, Dartigues JF, Hammond CJ, Pfeiffer N, Salonikiou A, van Duijn CM, Vingerling JR, Luben RN, Mirshahi A, Lamparter J, Klaver CC, Jansonius NM, Foster PJ; European Eye Epidemiology (E³) Consortium.

Eur J Epidemiol. 2016 Nov;31(11):1101-1111. doi: 10.1007/s10654-016-0191-1. Epub 2016 Sep 9.

49.

[Ranibizumab and exudative age-related macular degeneration: 5-year multicentric functional and anatomical results in real-life practice].

Boulanger-Scemama E, Sayag D, Ha Chau Tran T, Quaranta-El Maftouhi M, Rumen F, Creuzot-Garcher C, Blanco Garavito R, Jung C, Souied E.

J Fr Ophtalmol. 2016 Oct;39(8):668-674. doi: 10.1016/j.jfo.2016.06.001. Epub 2016 Sep 5. French.

50.

Clinical Characteristics and Risk Factors of Extensive Macular Atrophy with Pseudodrusen: The EMAP Case-Control National Clinical Trial.

Douillard A, Picot MC, Delcourt C, Lacroux A, Zanlonghi X, Puech B, Defoort-Dhelemmes S, Drumare I, Jozefowicz E, Bocquet B, Baudoin C, Al-Dain Marzouka N, Perez-Roustit S, Arsène S, Gissot V, Devin F, Arndt C, Wolff B, Mauget-Faÿsse M, Quaranta M, Mura T, Deplanque D, Oubraham H, Cohen SY, Gastaud P, Zambrowsky O, Creuzot-Garcher C, Mohand Saïd S, Blanco Garavito R, Souied E, Sahel JA, Audo I, Hamel C, Meunier I.

Ophthalmology. 2016 Sep;123(9):1865-73. doi: 10.1016/j.ophtha.2016.05.018. Epub 2016 Jun 16.

PMID:
27320518

Supplemental Content

Loading ...
Support Center